CIK 0001906324
- Large accelerated filer
QuidelOrtho Corp
Sign in to watch- Ticker
- QDEL
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Jan 1
- Entity type
- Operating
- EIN
- 874496285
- Phone
- +1 858-552-1100
- Business address
- 9975 SUMMERS RIDGE ROAD, SAN DIEGO, CA, 92121
- Former names
- Coronado Topco, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-31 | Kroll Werner SVP, Research & Development | Grant or award | +3,547 | 23,393 | ||
| 2023-01-31 | Kroll Werner SVP, Research & Development | Shares withheld for taxes | −1,840 | $85.61 | $158K | 21,553 |
| 2023-01-31 | Kroll Werner SVP, Research & Development | Exercise or conversion · Restricted Stock Units | −3,547 | 7,095 | ||
| 2023-01-31 | Hodges Michelle A. SVP, General Counsel | Grant or award | +1,609 | 4,633 | ||
| 2023-01-31 | Hodges Michelle A. SVP, General Counsel | Shares withheld for taxes | −643 | $85.61 | $55K | 3,990 |
| 2023-01-31 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −1,609 | 4,830 | ||
| 2023-01-31 | Bujarski Robert Joseph EVP & COO | Grant or award | +3,219 | 33,204 | ||
| 2023-01-31 | Bujarski Robert Joseph EVP & COO | Shares withheld for taxes | −1,771 | $85.61 | $152K | 31,433 |
| 2023-01-31 | Bujarski Robert Joseph EVP & COO | Exercise or conversion · Restricted Stock Units | −3,219 | 9,659 | ||
| 2023-01-31 | BRYANT DOUGLAS C President & CEO | Grant or award | +6,760 | 513,422 | ||
| 2023-01-31 | BRYANT DOUGLAS C President & CEO | Shares withheld for taxes | −3,406 | $85.61 | $292K | 510,016 |
| 2023-01-31 | BRYANT DOUGLAS C President & CEO | Exercise or conversion · Restricted Stock Units | −6,760 | 20,283 | ||
| 2023-01-30 | Busky Joseph M Chief Financial Officer | Grant or award · Non-Qualified Stock Option | +21,012 | 21,012 | ||
| 2022-12-31 | Dilsaver Evelyn S Director | Grant or award | +69 | 481 | ||
| 2022-12-31 | Dilsaver Evelyn S Director | Exercise or conversion · Restricted Stock Units | −69 | 68 | ||
| 2022-12-01 | Hodges Michelle A. SVP, General Counsel | Grant or award | +238 | 3,143 | ||
| 2022-12-01 | Hodges Michelle A. SVP, General Counsel | Shares withheld for taxes | −119 | $93.65 | $11K | 3,024 |
| 2022-12-01 | Hodges Michelle A. SVP, General Counsel | Exercise or conversion · Restricted Stock Units | −238 | 476 | ||
| 2022-11-18 | Bujarski Robert Joseph President & COO | Grant or award | +1,033 | 30,529 | ||
| 2022-11-18 | Bujarski Robert Joseph President & COO | Shares withheld for taxes | −544 | $88.40 | $48K | 29,985 |
Page 40 of 50 · 990 trades